SCHEDULE: JPMorgan Chase & Co. Updates Passive Stake in Oscar Health, Inc.

JPMorgan Chase & Co. has updated its passive ownership stake in Oscar Health, Inc., reporting a 4.5% beneficial ownership of Class A Common Stock.

Summary

• JPMorgan Chase & Co. filed an Amendment No. 1 to Schedule 13G regarding its ownership in Oscar Health, Inc.
• The filing reports beneficial ownership of 9,950,789 shares of Oscar Health, Inc. Class A Common Stock.
• This represents 4.5% of the Class A Common Stock outstanding.
• JPMorgan Chase & Co. holds sole voting power over 9,258,561 shares and sole dispositive power over 9,907,930 shares.
• Shared voting power is 0 shares, and shared dispositive power is 15,659 shares.
• The filing indicates the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• The filing was made by JPMorgan Chase & Co. as a parent holding company or control person.

Sentiment

Score: 5

Explanation: This is a neutral regulatory filing reporting a passive ownership stake. It does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or outlook.

Positives

• The filing indicates a significant institutional holding by JPMorgan Chase & Co. in Oscar Health, Inc.
• The holding is stated to be for ordinary course of business, not for control, indicating a passive investment.

Negatives

• The filing indicates JPMorgan Chase & Co. holds less than 5% of the class, which means they are not a major activist investor.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.

Industry Context

This filing reflects a passive institutional investment by a major financial institution, JPMorgan Chase & Co., in a healthcare technology company, Oscar Health, Inc. Such filings are routine disclosures of significant ownership stakes by large asset managers or banks.

Stakeholder Impact

• This filing primarily impacts shareholders by providing transparency on significant institutional ownership. It confirms a major financial institution's passive investment in the company.

Key Dates

Recommendation

This Schedule 13G/A filing is a routine disclosure of a passive ownership stake by JPMorgan Chase & Co. in Oscar Health, Inc. It does not contain financial performance data, strategic updates, or forward-looking guidance from the issuer that would warrant a change in investment recommendation. The presence of a large institutional investor is generally a neutral to slightly positive signal, but without further operational or financial details, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more comprehensive company updates.

Keywords

Oscar Health, JPMorgan Chase, SEC filing, Schedule 13G, beneficial ownership, Class A Common Stock, institutional ownership